Is OrganiGram Holdings Stock a Good Investment?
OrganiGram Holdings Investment Advice | OGI |
- Examine OrganiGram Holdings' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research OrganiGram Holdings' leadership team and their track record. Good management can help OrganiGram Holdings navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact OrganiGram Holdings' business and its evolving consumer preferences.
- Compare OrganiGram Holdings' performance and market position to its competitors. Analyze how OrganiGram Holdings is positioned in terms of product offerings, innovation, and market share.
- Check if OrganiGram Holdings pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about OrganiGram Holdings' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in OrganiGram Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if OrganiGram Holdings is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine OrganiGram Holdings Stock
Researching OrganiGram Holdings' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.06. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. OrganiGram Holdings recorded a loss per share of 1.84. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 7th of July 2023.
To determine if OrganiGram Holdings is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding OrganiGram Holdings' research are outlined below:
| OrganiGram Holdings had very high historical volatility over the last 90 days | |
| OrganiGram Holdings may become a speculative penny stock | |
| The company reported the last year's revenue of 149.21 M. Reported Net Loss for the year was (229.48 M) with profit before taxes, overhead, and interest of 35.07 M. | |
| OrganiGram Holdings has about 127.36 M in cash with (35.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| OrganiGram Holdings has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Closing Bell Organigram Holdings Inc down on Wednesday - The Globe and Mail |
OrganiGram Holdings Quarterly Cost Of Revenue |
|
OrganiGram Holdings uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in OrganiGram Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to OrganiGram Holdings' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 9th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 17th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact OrganiGram Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises OrganiGram Holdings' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-30 | 2023-08-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2017-12-18 | 2017-11-30 | -0.01 | -0.02 | -0.01 | 100 | ||
2017-07-28 | 2017-05-31 | -0.007 | -0.02 | -0.013 | 185 | ||
2022-01-11 | 2021-11-30 | -0.02 | -0.003 | 0.017 | 85 | ||
2022-04-12 | 2022-02-28 | -0.03 | -0.01 | 0.02 | 66 | ||
2020-01-14 | 2019-11-30 | -0.03 | -0.01 | 0.02 | 66 | ||
2018-04-24 | 2018-02-28 | -0.01 | 0.01 | 0.02 | 200 | ||
2021-11-23 | 2021-08-31 | -0.06 | -0.09 | -0.03 | 50 |
Know OrganiGram Holdings' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OrganiGram Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OrganiGram Holdings backward and forwards among themselves. OrganiGram Holdings' institutional investor refers to the entity that pools money to purchase OrganiGram Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Susquehanna International Group, Llp | 2023-12-31 | 102.6 K | Two Sigma Investments Llc | 2023-12-31 | 84 K | Goldman Sachs Group Inc | 65.4 K | Two Sigma Advisers, Llc | 2023-12-31 | 57.1 K | Vontobel Holding Ltd. | 2023-12-31 | 54.3 K | Bank Of America Corp | 2023-12-31 | 45.3 K | Group One Trading, Lp | 2023-12-31 | 42 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 40.8 K | Canton Hathaway, Llc | 2023-12-31 | 37.8 K | Mirae Asset Global Investments (korea) Co Ltd | 2023-12-31 | 1.2 M | Renaissance Technologies Corp | 2023-12-31 | 522 K |
OrganiGram Holdings' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 197.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OrganiGram Holdings's market, we take the total number of its shares issued and multiply it by OrganiGram Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
OrganiGram Holdings' profitablity analysis
OrganiGram Holdings' profitability indicators refer to fundamental financial ratios that showcase OrganiGram Holdings' ability to generate income relative to its revenue or operating costs. If, let's say, OrganiGram Holdings is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, OrganiGram Holdings' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of OrganiGram Holdings' profitability requires more research than a typical breakdown of OrganiGram Holdings' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.02) | (0.03) | |
| Return On Equity | (0.03) | (0.03) |
Determining OrganiGram Holdings' profitability involves analyzing its financial statements and using various financial metrics to determine if OrganiGram Holdings is a good buy. For example, gross profit margin measures OrganiGram Holdings' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of OrganiGram Holdings' profitability and make more informed investment decisions.
The data published in OrganiGram Holdings' official financial statements usually reflect OrganiGram Holdings' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of OrganiGram Holdings. For example, before you start analyzing numbers published by OrganiGram accountants, it's critical to develop an understanding of what OrganiGram Holdings' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of OrganiGram Holdings' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OrganiGram Holdings' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in OrganiGram Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OrganiGram Holdings. Please utilize our Beneish M Score to check the likelihood of OrganiGram Holdings' management manipulating its earnings.
Evaluate OrganiGram Holdings' management efficiency
OrganiGram Holdings has Return on Asset of (0.0556) % which means that on every $100 spent on assets, it lost $0.0556. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5453) %, meaning that it generated no profit with money invested by stockholders. OrganiGram Holdings' management efficiency ratios could be used to measure how well OrganiGram Holdings manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.03. The current Return On Capital Employed is estimated to decrease to -0.08. As of now, OrganiGram Holdings' Intangible Assets are increasing as compared to previous years. The OrganiGram Holdings' current Intangibles To Total Assets is estimated to increase to 0.10, while Total Assets are projected to decrease to under 251.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 6.58 | 6.91 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 5.85 | 3.06 | |
| Enterprise Value Over EBITDA | (24.31) | (23.09) | |
| Price Book Value Ratio | 0.86 | 0.81 | |
| Enterprise Value Multiple | (24.31) | (23.09) | |
| Price Fair Value | 0.86 | 0.81 | |
| Enterprise Value | 369.7 M | 185.6 M |
The analysis of OrganiGram Holdings' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze OrganiGram Holdings' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of OrganiGram Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.101 |
Basic technical analysis of OrganiGram Stock
As of the 3rd of May, OrganiGram Holdings holds the Semi Deviation of 5.18, risk adjusted performance of 0.0507, and Coefficient Of Variation of 1542.32. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OrganiGram Holdings, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for OrganiGram Holdings, which can be compared to its competitors. Please check OrganiGram Holdings information ratio, as well as the relationship between the value at risk and expected short fall to decide if OrganiGram Holdings is priced some-what accurately, providing market reflects its current price of 1.88 per share. Please also confirm OrganiGram Holdings total risk alpha, which is currently at (0.04) to check out the company can sustain itself at a future point.Understand OrganiGram Holdings' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing OrganiGram Holdings' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0507 | |||
| Market Risk Adjusted Performance | 0.1762 | |||
| Mean Deviation | 4.6 | |||
| Semi Deviation | 5.18 | |||
| Downside Deviation | 5.55 | |||
| Coefficient Of Variation | 1542.32 | |||
| Standard Deviation | 6.23 | |||
| Variance | 38.77 | |||
| Information Ratio | 0.056 | |||
| Jensen Alpha | 0.2867 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0628 | |||
| Treynor Ratio | 0.1662 | |||
| Maximum Drawdown | 35.2 | |||
| Value At Risk | (8.30) | |||
| Potential Upside | 11.29 | |||
| Downside Variance | 30.81 | |||
| Semi Variance | 26.88 | |||
| Expected Short fall | (5.46) | |||
| Skewness | 0.5351 | |||
| Kurtosis | 1.25 |
| Risk Adjusted Performance | 0.0507 | |||
| Market Risk Adjusted Performance | 0.1762 | |||
| Mean Deviation | 4.6 | |||
| Semi Deviation | 5.18 | |||
| Downside Deviation | 5.55 | |||
| Coefficient Of Variation | 1542.32 | |||
| Standard Deviation | 6.23 | |||
| Variance | 38.77 | |||
| Information Ratio | 0.056 | |||
| Jensen Alpha | 0.2867 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0628 | |||
| Treynor Ratio | 0.1662 | |||
| Maximum Drawdown | 35.2 | |||
| Value At Risk | (8.30) | |||
| Potential Upside | 11.29 | |||
| Downside Variance | 30.81 | |||
| Semi Variance | 26.88 | |||
| Expected Short fall | (5.46) | |||
| Skewness | 0.5351 | |||
| Kurtosis | 1.25 |
Consider OrganiGram Holdings' intraday indicators
OrganiGram Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OrganiGram Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 70423.99 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 1.93 | |||
| Day Typical Price | 1.91 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.04) | |||
| Relative Strength Index | 38.97 |
OrganiGram Stock media impact
Far too much social signal, news, headlines, and media speculation about OrganiGram Holdings that are available to investors today. That information is available publicly through OrganiGram media outlets and privately through word of mouth or via OrganiGram internal channels. However, regardless of the origin, that massive amount of OrganiGram data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OrganiGram Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OrganiGram Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OrganiGram Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OrganiGram Holdings alpha.
OrganiGram Holdings Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards OrganiGram Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in OrganiGram Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
OrganiGram Holdings Corporate Management
Elected by the shareholders, the OrganiGram Holdings' board of directors comprises two types of representatives: OrganiGram Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OrganiGram. The board's role is to monitor OrganiGram Holdings' management team and ensure that shareholders' interests are well served. OrganiGram Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OrganiGram Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | Chief Officer | Profile | |
| Beena Goldenberg | CEO Director | Profile | |
| Helen Martin | Chief Secretary | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Megan McCrae | Senior Communications | Profile | |
| Amy Schwalm | VP Relations | Profile | |
| CFA CA | Chief Officer | Profile |
How to buy OrganiGram Stock?
To provide specific investment advice or recommendations on OrganiGram Holdings stock, we recommend investors consider the following general factors when evaluating OrganiGram Holdings. This will help you to make an informed decision on whether to include OrganiGram Holdings in one of your diversified portfolios:- Examine OrganiGram Holdings' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research OrganiGram Holdings' leadership team and their track record. Good management can help OrganiGram Holdings navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact OrganiGram Holdings' business and its evolving consumer preferences.
- Compare OrganiGram Holdings' performance and market position to its competitors. Analyze how OrganiGram Holdings is positioned in terms of product offerings, innovation, and market share.
- Check if OrganiGram Holdings pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about OrganiGram Holdings' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in OrganiGram Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if OrganiGram Holdings is a good investment.
Already Invested in OrganiGram Holdings?
The danger of trading OrganiGram Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of OrganiGram Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than OrganiGram Holdings. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile OrganiGram Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.Note that the OrganiGram Holdings information on this page should be used as a complementary analysis to other OrganiGram Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is OrganiGram Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between OrganiGram Holdings' value and its price, as these two are different measures arrived at by various means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.